Intermittent antipsychotic medication and mortality in institutionalized older adults: A scoping review
International Journal of Geriatric Psychiatry Apr 28, 2019
Randle JM, et al. - Researchers conducted a scoping review of 28 articles in order to investigate the temporal association between antipsychotic use and mortality risk for older institutionalized adults. Older adults with dementia exhibited a higher risk of mortality when received antipsychotic medications. Compared to atypical preparations, conventional antipsychotics present a higher risk. Within 30 to 40 days of initiating antipsychotic treatment, mortality risk seems highest. Some previously unrecognized illness, comorbidity, change in health status, or increased frailty, rather than an idiosyncrasy of the antipsychotic itself, seemed actually attributing to the increased mortality.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries